Skip to main content
PMC home page
American Journal of Public Health logoLink to American Journal of Public Health
. 1995 Dec;85(12):1666–1672. doi: 10.2105/ajph.85.12.1666

A model for estimating the impact of changes in children's vaccines.

K N Simpson 1, A K Biddle 1, N R Rabinovich 1
PMCID: PMC1615744  PMID: 7503342

Abstract

OBJECTIVES. To assist in strategic planning for the improvement of vaccines and vaccine programs, an economic model was developed and tested that estimates the potential impact of vaccine innovations on health outcomes and costs associated with vaccination and illness. METHODS. A multistep, iterative process of data extraction/integration was used to develop the model and the scenarios. Parameter replication, sensitivity analysis, and expert review were used to validate the model. RESULTS. The greatest impact on the improvement of health is expected to result from the production of less reactogenic vaccines that require fewer inoculations for immunity. The greatest economic impact is predicted from improvements that decrease the number of inoculations required. CONCLUSIONS. Scenario analysis may be useful for integrating health outcomes and economic data into decision making. For childhood infections, this analysis indicates that large cost savings can be achieved in the future if we can improve vaccine efficacy so that the number of required inoculations is reduced. Such an improvement represents a large potential "payback" for the United States and might benefit other countries.

Full text

PDF
1666

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bloch A. B., Orenstein W. A., Stetler H. C., Wassilak S. G., Amler R. W., Bart K. J., Kirby C. D., Hinman A. R. Health impact of measles vaccination in the United States. Pediatrics. 1985 Oct;76(4):524–532. [PubMed] [Google Scholar]
  2. Bloom B. S., Knorr R. S., Evans A. E. The epidemiology of disease expenses. The costs of caring for children with cancer. JAMA. 1985 Apr 26;253(16):2393–2397. [PubMed] [Google Scholar]
  3. Cutts F. T., Orenstein W. A., Bernier R. H. Causes of low preschool immunization coverage in the United States. Annu Rev Public Health. 1992;13:385–398. doi: 10.1146/annurev.pu.13.050192.002125. [DOI] [PubMed] [Google Scholar]
  4. Davis S. F., Strebel P. M., Atkinson W. L., Markowitz L. E., Sutter R. W., Scanlon K. S., Friedman S., Hadler S. C. Reporting efficiency during a measles outbreak in New York City, 1991. Am J Public Health. 1993 Jul;83(7):1011–1015. doi: 10.2105/ajph.83.7.1011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Fine P. E., Clarkson J. A. Reflections on the efficacy of pertussis vaccines. Rev Infect Dis. 1987 Sep-Oct;9(5):866–883. doi: 10.1093/clinids/9.5.866. [DOI] [PubMed] [Google Scholar]
  6. Hay J. W., Daum R. S. Cost-benefit analysis of two strategies for prevention of Haemophilus influenzae type b infection. Pediatrics. 1987 Sep;80(3):319–329. [PubMed] [Google Scholar]
  7. Hinman A. R., Koplan J. P. Pertussis and pertussis vaccine. Reanalysis of benefits, risks, and costs. JAMA. 1984 Jun 15;251(23):3109–3113. doi: 10.1001/jama.251.23.3109. [DOI] [PubMed] [Google Scholar]
  8. Marks J. S., Hayden G. F., Orenstein W. A. Methodologic issues in the evaluation of vaccine effectiveness: measles vaccine at 12 vs. 15 months. Am J Epidemiol. 1982 Sep;116(3):510–523. doi: 10.1093/oxfordjournals.aje.a113435. [DOI] [PubMed] [Google Scholar]
  9. Miller M. E., Welch W. P. Physician charges in the hospital. Exploring episodes of care for controlling volume growth. Med Care. 1992 Jul;30(7):630–645. [PubMed] [Google Scholar]
  10. Orenstein W. A., Markowitz L., Preblud S. R., Hinman A. R., Tomasi A., Bart K. J. Appropriate age for measles vaccination in the United States. Dev Biol Stand. 1986;65:13–21. [PubMed] [Google Scholar]
  11. Stieb D. M., Frayha H. H., Oxman A. D., Shannon H. S., Hutchison B. G., Crombie F. S. Effectiveness of Haemophilus influenzae type b vaccines. CMAJ. 1990 Apr 1;142(7):719–733. [PMC free article] [PubMed] [Google Scholar]
  12. Sutter R. W., Cochi S. L. Pertussis hospitalizations and mortality in the United States, 1985-1988. Evaluation of the completeness of national reporting. JAMA. 1992 Jan 15;267(3):386–391. [PubMed] [Google Scholar]
  13. White C. C., Koplan J. P., Orenstein W. A. Benefits, risks and costs of immunization for measles, mumps and rubella. Am J Public Health. 1985 Jul;75(7):739–744. doi: 10.2105/ajph.75.7.739. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Wright J. A., Marcuse E. K. Immunization practices of Washington State pediatricians--1989. Am J Dis Child. 1992 Sep;146(9):1033–1036. [PubMed] [Google Scholar]
  15. Zell E. R., Dietz V., Stevenson J., Cochi S., Bruce R. H. Low vaccination levels of US preschool and school-age children. Retrospective assessments of vaccination coverage, 1991-1992. JAMA. 1994 Mar 16;271(11):833–839. [PubMed] [Google Scholar]

Articles from American Journal of Public Health are provided here courtesy of American Public Health Association

RESOURCES